Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Skip to chapters
Contents · Peripheral SpA
Professional collection · English

Peripheral / undifferentiated SpA

A clinical framework for peripheral phenotype, diagnostic certainty, evidence applicability and longitudinal reassessment.

Professional collectionEvidence reviewed:

Professional Essentials and selected introductory chapters are open. Access to other professional chapters follows the site’s membership policy.

Choose your starting point · clinical routes

Chapters

Definitions and disease framework

  1. Chapter 1: Peripheral SpA, PsA, uSpA and Diagnostic Boundaries

    Separate peripheral phenotype, disease association and diagnostic confidence before choosing a treatment pathway or interpreting a study.

    Open access
  2. Chapter 2: Epidemiology and Clinical Heterogeneity

    Read peripheral SpA epidemiology through its denominator, classification method and referral setting; avoid turning cohort proportions into patient predictions.

    Professional access
  3. Chapter 3: Peripheral Tissue Biology and Therapeutic Targets

    Connect synovium, enthesis, dactylitis and bone responses to therapeutic targets while keeping mechanistic plausibility separate from clinical efficacy.

    Professional access

Diagnosis and phenotyping

  1. Chapter 4: Phenotyping Across Peripheral and Extra-musculoskeletal Domains

    Build a reproducible domain record that distinguishes active inflammation, prior disease and functional impact before choosing treatment.

    Open access
  2. Chapter 5: Diagnosis, Classification and the 2025 ASAS–SPARTAN Revised Axial Criteria

    Use peripheral and axial classification in their intended populations, with explicit criteria versions and a separate clinical diagnostic judgment.

    Open access
  3. Chapter 6: Differential Diagnosis and Important Mimics

    Prioritize dangerous and plausible alternatives to peripheral SpA by the presenting problem: hot joint, persistent synovitis, enthesis pain or swollen digit.

    Open access
  4. Chapter 7: Testing That Changes Management

    Choose laboratory and synovial-fluid tests by the decision they address: infection, crystals, competing disease, inflammatory burden or treatment safety.

    Professional access
  5. Chapter 8: Imaging in Clinical Context: Ultrasound, MRI and Radiography

    Choose imaging by the tissue and decision, interpret inflammatory and structural lesions together, and understand what DEUS can and cannot establish.

    Professional access

Measurement

  1. Chapter 9: Measuring Peripheral Arthritis, Enthesitis, Dactylitis and Patient Impact

    Use DAPSA44 for its intended peripheral arthritis domain and complement it with enthesis, dactylitis, organ and patient-impact assessments.

    Open access

Treatment

  1. Chapter 10: Initial Management and Local Therapy

    Build an initial peripheral SpA plan around confirmed inflammation, safe local care, rehabilitation and clear reassessment triggers.

    Professional access
  2. Chapter 11: Conventional DMARDs: Evidence and Limits

    Read sulfasalazine, methotrexate and leflunomide evidence by population and manifestation, with practical rules for response and reassessment.

    Professional access
  3. Chapter 12: TNF Inhibition in Peripheral SpA: Direct Evidence and Early-Disease Trials

    Compare ABILITY-2, CRESPA and SPARTACUS by population, study design, publication status and the clinical question each can answer.

    Professional access
  4. Chapter 13: Beyond TNF: Direct Evidence, Mixed Populations and Extrapolation

    Distinguish IL-17, IL-23, JAK and TYK2 evidence by population, including 2026 PsA developments and limits in nonpsoriatic pSpA.

    Professional access
  5. Chapter 14: Choosing Treatment Across Organ Domains

    Choose peripheral SpA treatment across joints, entheses, skin, bowel, eyes and axial disease, with explicit safety and evidence boundaries.

    Professional access

Longitudinal care

  1. Chapter 15: Diagnostic Evolution and Reassessment

    Reassess peripheral SpA over time: distinguish newly apparent disease associations, changing phenotype and an alternative diagnosis.

    Professional access
  2. Chapter 16: Persistent Symptoms: Active Inflammation, Damage or Another Problem?

    Assess persistent symptoms by separating inflammation, damage, mechanical load, alternative disease and other pain contributors.

    Professional access
  3. Chapter 17: Remission, Treatment Reduction and Drug-Free Disease Control

    Define peripheral SpA remission carefully and distinguish dose reduction, withdrawal and drug-free control using the CRESPA evidence.

    Professional access
  4. Chapter 18: Long-Term Outcomes, Function and Prognosis

    Discuss peripheral SpA prognosis through inflammatory control, function, participation and diagnostic evolution without deterministic predictions.

    Professional access

Safety and special populations

  1. Chapter 19: Treatment Safety, Infection, Vaccination, Surgery and Coordinated Care

    Build a drug-specific safety plan for peripheral SpA, including infection screening, vaccination, surgery and shared specialty care.

    Professional access
  2. Chapter 20: Pregnancy, Lactation, Older Age and Multimorbidity

    Adapt peripheral SpA decisions for reproduction, older age and comorbidity using drug-specific evidence and coordinated care.

    Professional access
  3. Chapter 21: Juvenile-onset Disease Entering Adult Care

    Transfer juvenile-onset SpA into adult care with a preserved disease history, current phenotype and uninterrupted monitoring.

    Professional access

Evidence and future directions

  1. Chapter 22: Reading the Peripheral SpA Evidence Base

    Read peripheral SpA studies by separating population applicability, study design, publication status and the clinical decision supported.

    Professional access
  2. Chapter 23: Biomarkers and Precision Phenotyping

    Distinguish diagnostic, prognostic and predictive biomarkers from exploratory findings, and assess whether a test changes peripheral SpA care.

    Professional access
  3. Chapter 24: Early Intervention and Disease Modification

    Assess the peripheral SpA window-of-opportunity hypothesis using CRESPA and SPARTACUS without equating early response with disease modification.

    Professional access
  4. Chapter 25: Emerging Therapies and the Research Agenda

    Explore the peripheral SpA research questions that could change care, with current trial status and explicit separation from PsA-derived evidence.

    Professional access

Professional quizzes

Apply the collection in short clinical cases. Open demos need no registration; standard quizzes use Professional membership, an active pass or a redeemed access code.

20 quizzes · English

PSPA-PRO-QUIZ-01 · English · Open demo

One Label, Three Questions

Phenotype, disease context and diagnostic confidence in peripheral and undifferentiated SpA. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-02 · English · Open demo

The Domain Record

Phenotyping arthritis, entheses, dactylitis and extra-musculoskeletal disease before choosing treatment. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-03 · English · Professional access

Criteria in Their Place

Peripheral and axial classification, the 2025 ASAS–SPARTAN revision and the separate task of clinical diagnosis. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-04 · English · Professional access

Before You Call It a Flare

Infection, crystals, other inflammatory disease and mechanical mimics of peripheral SpA. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-05 · English · Professional access

Reading the Score

DAPSA44, enthesitis and dactylitis measures, and what a number does and does not say about the patient. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-06 · English · Professional access

First Moves

Local therapy, NSAIDs, glucocorticoids and rehabilitation at the start of peripheral SpA care. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-07 · English · Professional access

The Limits of Conventional DMARDs

Sulfasalazine, methotrexate and leflunomide: what the trials tested and what they did not. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-08 · English · Professional access

Three Trials, Three Questions

ABILITY-2, CRESPA and SPARTACUS: what each TNF-inhibitor trial can and cannot tell you. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-09 · English · Professional access

Borrowed Evidence

IL-17, IL-23, JAK and TYK2 inhibition: direct, PsA-derived and extrapolated evidence in peripheral SpA. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-10 · English · Professional access

One Patient, Several Organs

Choosing treatment when joints, entheses, skin, bowel, eyes and reproductive plans compete. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-11 · English · Professional access

When the Label Moves

Reassessing peripheral SpA over time: new associations, a changing phenotype and alternative diagnoses. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-12 · English · Professional access

Still Hurting

Persistent symptoms: separating ongoing inflammation, damage, mechanical load, another disease and other pain contributors. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-13 · English · Professional access

Stepping Down

Defining remission, and distinguishing dose reduction, withdrawal and drug-free disease control. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-14 · English · Professional access

What Will Happen to Me?

Prognosis as a set of trajectories: inflammatory control, function, participation and treatment burden. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-15 · English · Professional access

The Safety Plan

Infection screening, acute illness, vaccination, surgery and shared care around immunomodulatory treatment. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-16 · English · Professional access

What Was Counted?

Denominators, case definitions and referral settings behind the numbers quoted for peripheral SpA. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-17 · English · Professional access

From Pathway to Prescription

What tissue biology can and cannot tell you about treating synovium, enthesis and digit. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-18 · English · Professional access

A Test for a Decision

Choosing laboratory, microbiological and safety tests by the decision each one is meant to serve. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-19 · English · Professional access

Reading the Image in Context

Ultrasound, MRI and radiography: lesion, technique and the limits of what a study establishes. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

PSPA-PRO-QUIZ-20 · English · Professional access

When Circumstances Change the Plan

Pregnancy, lactation, paternal exposure, older age, cardiovascular risk and a history of cancer. Case-based self-assessment for healthcare professionals.

Open the quiz →

Reviewed

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Peripheral SpASpondyloarthritis